Details
Stereochemistry | ACHIRAL |
Molecular Formula | C33H36N4O6 |
Molecular Weight | 584.6621 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C=C)\C(NC1=O)=C\C2=C(C)C(CCC(O)=O)=C(CC3=C(CCC(O)=O)C(C)=C(N3)\C=C4/NC(=O)C(C=C)=C4C)N2
InChI
InChIKey=BPYKTIZUTYGOLE-IFADSCNNSA-N
InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-
Molecular Formula | C33H36N4O6 |
Molecular Weight | 584.6621 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Bilirubin is an orange-yellow pigment made during the normal breakdown of red blood cells. Bilirubin passes through the liver and is excreted out of the body. Occasionally, higher bilirubin levels may indicate an increased rate of destruction of red blood cells (hemolysis). A high level of bilirubin in the blood is called hyperbilirubinemia. High bilirubin levels can cause jaundice. Jaundice makes the skin and the whites of the eyes appear yellow, due to the brown and yellow bilirubin in the blood. Phototherapy for neonatal is one of the treatment methods against hyperbilirubinemia. Light absorption by bilirubin in the skin transforms the native Z,Z-bilirubin to conformational photoisomers Z,E-bilirubin and E,Z-bilirubin and structural photoisomers E,Z-lumirubin and E,E-lumirubin. Formation and excretion of Z,E-bilirubin and E,Z-lumirubin are both important routes of elimination of bilirubin through bile and urine, although the precise contributions of the various photoisomers to the overall elimination of bilirubin are still unknown.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Hepatic veno-occlusive disease associated to the use of azathioprine in a renal transplant recipient]. | 1996 Dec |
|
New concepts in bilirubin and jaundice: report of the Third International Bilirubin Workshop, April 6-8, 1995, Trieste, Italy. | 1996 Nov |
|
Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion. | 1998 |
|
Haemolytic anaemia due to metformin. | 2000 Feb |
|
Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. | 2000 May |
|
Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2. | 2000 Sep |
|
Effects on extrahepatic UDP-glucuronosyltransferases in hypophysectomized rat. | 2002 Aug |
|
Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. | 2002 Jul |
|
[Clinical manifestation and ultrasonic characteristics of five patients with acute arsenic poisoning]. | 2003 Dec |
|
Heme oxygenase inhibits human airway smooth muscle proliferation via a bilirubin-dependent modulation of ERK1/2 phosphorylation. | 2003 Jul 18 |
|
Synergistic role of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7alpha-hydroxylase in the pathogenesis of manganese-bilirubin-induced cholestasis in rats. | 2003 Jun |
|
Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat. | 2004 Dec |
|
Pancreaticoduodenectomy: a 20-year experience in 516 patients. | 2004 Jul |
|
Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo. | 2004 Jul 20 |
|
Importance of serum bile acids determination in adolescents with juvenile hyperbilirubinaemia. | 2004 Jun |
|
Transcutaneous bilirubin measurements and serum total bilirubin levels in indigenous African infants. | 2004 Jun |
|
[Decreased peripheral nerve conduction velocity may be associated with lower-serum level of vitamin E in patients with infantile hepatitis syndrome]. | 2004 May |
|
On the origin of amniotic fluid bilirubin. | 2004 May |
|
Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. | 2004 Oct |
|
The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin. | 2004 Oct 15 |
|
Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity. | 2004 Sep |
|
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine. | 2004 Sep |
|
Role of microtubules in estradiol-17beta-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity. | 2005 Feb |
|
Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the glucuronidation of 2-(4-chlorophenyl)- 5-(2-furyl)-4-oxazoleacetic acid (TA-1801A). | 2005 Jun |
|
Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide. | 2005 Jun 24 |
|
Transcriptional regulation of human UGT1A1 gene expression: activated glucocorticoid receptor enhances constitutive androstane receptor/pregnane X receptor-mediated UDP-glucuronosyltransferase 1A1 regulation with glucocorticoid receptor-interacting protein 1. | 2005 Mar |
|
Impaired expression of hepatic multidrug resistance protein 2 is associated with posthepatectomy hyperbilirubinemia in patients with biliary cancer. | 2005 Sep |
|
Carbon monoxide donors or heme oxygenase-1 (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death. | 2008 Feb 1 |
|
Protective effects of bilirubin against cyclophosphamide induced hemorrhagic cystitis in rats. | 2008 Mar |
|
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV. | 2008 Nov |
|
Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin. | 2011 |
|
Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-κB leads to hyperbilirubinemia. | 2012 Jan |
|
Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemia. | 2013 Nov |
|
Mitochondrial Channel Opener Diazoxide Attenuates Hypoxia-Induced sFlt-1 Release in Human Choriocarcinoma Cells. | 2014 Apr |
|
Physiological concentrations of unconjugated bilirubin prevent oxidative stress-induced hepatocanalicular dysfunction and cholestasis. | 2014 Feb |
|
Heme-regulated eIF2α kinase plays a crucial role in protecting erythroid cells against Pb-induced hemolytic stress. | 2015 Mar 16 |
|
Role of brain cytochrome P450 mono-oxygenases in bilirubin oxidation-specific induction and activity. | 2016 Feb |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:07 GMT 2023
by
admin
on
Fri Dec 15 15:11:07 GMT 2023
|
Record UNII |
RFM9X3LJ49
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
89871-8
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
35194-0
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
54362-9
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
CFR |
21 CFR 862.1110
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
14421-2
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
59166-9
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
1978-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
77452-1
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
32303-0
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
14631-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
59827-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
39461-9
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
14423-8
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
CFR |
21 CFR 862.1115
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
12476-8
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
54363-7
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
53415-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
58941-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
1977-8
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
1975-2
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
14424-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
29767-1
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
77137-8
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
27198-1
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
49763-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
72925-1
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
70199-5
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
74906-9
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
47225-8
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
1974-5
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
47994-9
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
74434-2
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
13877-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
NCI_THESAURUS |
C304
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
14422-0
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
33870-7
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
48624-1
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
1972-9
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
11132-8
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
42719-5
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
89872-6
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
72898-0
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
1976-0
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
35193-2
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
43887-9
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
CFR |
21 CFR 862.1113
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
59828-4
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
1973-7
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
14420-4
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
||
|
LOINC |
43824-2
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C305
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
D001663
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
DTXSID8060905
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
RFM9X3LJ49
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
635-65-4
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
5280352
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
16990
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
RFM9X3LJ49
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
26685
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
m2492
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
BILIRUBIN
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY | |||
|
211-239-7
Created by
admin on Fri Dec 15 15:11:07 GMT 2023 , Edited by admin on Fri Dec 15 15:11:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE |
MINOR
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|